BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures

Cloning and Stem Cells

Volumn 11, Issue 3, 2009, Pages 427-435

  Hannan, Nicholas R F ^a   Jamshidi, Pegah ^a   Pera, Martin F ^b   Wolvetang, Ernst J ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 11; MYOSTATIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG INHIBITION; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION;

ACTIVIN RECEPTORS, TYPE I; ACTIVINS; ANIMALS; ANTIGENS, SURFACE; BENZAMIDES; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; COCULTURE TECHNIQUES; DIOXOLES; EMBRYONIC STEM CELLS; GROWTH DIFFERENTIATION FACTORS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MYOSTATIN; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD3 PROTEIN; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TIME FACTORS;

EID: 70349225807     PISSN: 15362302     EISSN: None     Source Type: Journal    
DOI: 10.1089/clo.2009.0024     Document Type: Article

References (20)

1. Amit, M., Carpenter, M.K., Inokuma, M.S, et al. (2000). Clonally derived human embryonic stem cell lines maintain plur-ipotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278.
2. Amit, M., Shariki, C., Margulets, V, et al. (2004). Feeder layer-and serum-free culture of human embryonic stem cells. Biol. Reprod. 70, 837-845. (Pubitemid 38233724)
3. Andersson, O., Reissmann, E., and Ibanez, C.F. (2006). Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep. 7, 831-837.
4. Armstrong, L., Hughs, O., Yung, S., et al. (2006). The role of PI3K=AKT, MAPK=ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15, 1894-1913.
5. Beattie, G.M., Lopez, A.D., Bucay, N., et al. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23, 489-495.
6. Fong, H., Hohenstein, K.A., and Donovan, P.J. (2008). Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26, 1931-1938.
7. Greber, B., Lehrach, H., and Adjaye, J. (2008). Control of early fate decisions in human ES cells by distinct states of TGFss pathway activity. Stem Cells Dev. 17, 1065-1077.
8. Lee, S.J., and McPherron, A.C. (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA 98, 9306-9311.
9. Levine, A.J., and Brivanlou, A.H. (2006). GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133, 209-216.
10. Mazerbourg, S., and Hsueh, A.J. (2006). Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone mor-phogenetic protein=growth differentiation factor ligands. Hum. Reprod. Update 12,373-383.
11. McLean, A.B., D'Amour, K.A., Jones, K.L., et al. (2007). Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25, 29-38.
12. McPherron, A.C., Lawler, A.M., and Lee, S.J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta super-family member. Nature 387, 83-90.
13. Oh, S.P., Yeo, C.Y., Lee, Y., et al. (2002). Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev 16, 2749-2754.
14. Rebbapragada, A., Benchabane, H., Wrana, J.L., et al. (2003). Myostatin signals through a transforming growth factor betalike signaling pathway to block adipogenesis. Mol. Cell Biol. 23, 7230-7242.
15. Reubinoff, B.E., Pera, M.F., Fong, C.Y., et al. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404.
16. Thomson, J.A., Itskovitz-Eldor, J, Shapiro, S.S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
17. Vallier, L., Alexander, M, and Pedersen, R.A. (2005). Activin= nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118(Pt. 19), 4495-4509.
18. Wu, H.H., Ivkovic, S, Murray, R.C., et al. (2003). Autoregulation of neurogenesis by GDF11. Neuron 37, 197-207.
19. Xiao, L., X. Yuan, X., and Sharkis, S.J. (2006). Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24, 1476-1486.
20. Xu, R.H., Sampsell-Barron, T.L., Gu, F., et al. (2008). NANOG is a direct target of TGFbeta=activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3, 196-206.